146 related articles for article (PubMed ID: 15522559)
1. Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence.
Bonenkamp JJ; Thompson JF; de Wilt JH; Doubrovsky A; de Faria Lima R; Kam PC
Eur J Surg Oncol; 2004 Dec; 30(10):1107-12. PubMed ID: 15522559
[TBL] [Abstract][Full Text] [Related]
2. Isolated limb perfusion with fotemustine after chemosensitization with dacarbazine in melanoma.
Pontes L; Lopes M; Ribeiro M; Santos JG; Azevedo MC
Melanoma Res; 1997 Oct; 7(5):417-9. PubMed ID: 9429225
[TBL] [Abstract][Full Text] [Related]
3. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
[TBL] [Abstract][Full Text] [Related]
4. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
Pathol Biol (Paris); 1990 Oct; 38(8):876-80. PubMed ID: 2274396
[No Abstract] [Full Text] [Related]
5. [Acquired myelodysplastic syndromes after treatment of melanoma with fotemustine and dacarbazine].
Perrot JL; Lanthier K; Benoit F; Graille MC; Guy C; Bertheas MF; Cambazard F
Ann Dermatol Venereol; 1995; 122(10):663-6. PubMed ID: 8687048
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Cancer; 2009 May; 115(9):1932-40. PubMed ID: 19288571
[TBL] [Abstract][Full Text] [Related]
7. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
Beasley GM; Caudle A; Petersen RP; McMahon NS; Padussis J; Mosca PJ; Zager JS; Hochwald SN; Grobmyer SR; Delman KA; Andtbacka RH; Noyes RD; Kane JM; Seigler H; Pruitt SK; Ross MI; Tyler DS
J Am Coll Surg; 2009 May; 208(5):706-15; discussion 715-7. PubMed ID: 19476821
[TBL] [Abstract][Full Text] [Related]
8. Isolated limb perfusion in locally advanced cutaneous melanoma.
Rossi CR; Foletto M; Pilati P; Mocellin S; Lise M
Semin Oncol; 2002 Aug; 29(4):400-9. PubMed ID: 12170443
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.
Kroon HM; Coventry BJ; Henderson MA; Barbour A; Serpell J; Smithers BM; Thompson JF
Eur J Surg Oncol; 2019 May; 45(5):832-837. PubMed ID: 30867095
[TBL] [Abstract][Full Text] [Related]
10. Positive phase II study in the treatment of advanced malignant melanoma with fotemustine.
Schallreuter KU; Wenzel E; Brassow FW; Berger J; Breitbart EW; Teichmann W
Cancer Chemother Pharmacol; 1991; 29(1):85-7. PubMed ID: 1742855
[TBL] [Abstract][Full Text] [Related]
11. Australian Multicenter Study of Isolated Limb Infusion for Melanoma.
Kroon HM; Coventry BJ; Giles MH; Henderson MA; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1096-103. PubMed ID: 26581203
[TBL] [Abstract][Full Text] [Related]
12. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
13. Phase I-II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities.
Rossi CR; Lejeune FJ; Pontes L; Foletto M; De Salvo GL; Pilati PL; Mocellin S; Ribeiro M; Lopes M; Lise M
Melanoma Res; 2003 Jun; 13(3):293-7. PubMed ID: 12777985
[TBL] [Abstract][Full Text] [Related]
14. Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms.
Turaga KK; Beasley GM; Kane JM; Delman KA; Grobmyer SR; Gonzalez RJ; Letson GD; Cheong D; Tyler DS; Zager JS
Arch Surg; 2011 Jul; 146(7):870-5. PubMed ID: 21768436
[TBL] [Abstract][Full Text] [Related]
15. Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.
Coventry BJ; Kroon HM; Giles MH; Henderson M; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM
J Surg Oncol; 2014 Jun; 109(8):780-5. PubMed ID: 24634160
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study.
Kenyon-Smith TJ; Kroon HM; Miura JT; Teras J; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Potdar A; Daou H; Sun J; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Smithers BM; Barbour A; Coventry BJ; Tyler DS; Zager JS; Thompson JF
Eur J Surg Oncol; 2020 Nov; 46(11):2140-2146. PubMed ID: 32739218
[TBL] [Abstract][Full Text] [Related]
17. A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.
Chai CY; Deneve JL; Beasley GM; Marzban SS; Chen YA; Rawal B; Grobmyer SR; Hochwald SN; Tyler DS; Zager JS
Ann Surg Oncol; 2012 May; 19(5):1637-43. PubMed ID: 22143576
[TBL] [Abstract][Full Text] [Related]
18. First Eastern European experience of isolated limb infusion for in-transit metastatic melanoma confined to the limb: Is it still an effective treatment option in the modern era?
Teras J; Kroon HM; Thompson JF; Teras M; Pata P; Mägi A; Teras RM; Boudinot SR
Eur J Surg Oncol; 2020 Feb; 46(2):272-276. PubMed ID: 31748147
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
Brady MS; Brown K; Patel A; Fisher C; Marx W
Ann Surg Oncol; 2006 Aug; 13(8):1123-9. PubMed ID: 16791448
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
Miura JT; Kroon HM; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y; Naqvi SMH; Potdar A; Daou H; Sun J; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Mark Smithers B; Coventry BJ; Tyler DS; Thompson JF; Zager JS
Ann Surg Oncol; 2019 Aug; 26(8):2486-2494. PubMed ID: 30911949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
